Study supports sex- and comorbidity-based cutoffs for stopping Barrett's surveillance
-
May 13
“Most physicians make future surveillance decisions heavily based on perceived risk for EAC without considering … life expectancy.”
Browse By
Biliary Tract
Colon
Esophagus
Liver
Pancreas
Small Bowel
Stomach
The GI hospitalist: A practice-changing health care opportunity
-
April 23
-
by Vasili Kalas, MD, PhD
The model is reshaping inpatient care, despite slow national adoption.
Pancreatic cystic lesions: A case-based approach
-
April 17
-
by Ross C.D. Buerlein, MD , Himesh B. Zaver, MD , Vanessa M. Shami, MD
Dr. Vanessa Shami, along with Drs. Ross Buerlein and Himesh Zaver, review pancreatic cysts in a case-based approach.
Navigating primary sclerosing cholangitis: Diagnosis and the 5 pillars of management
-
February 1
-
by Judy A. Trieu, MD, MPH, Mahesh Krishna, MD, David N. Assis, MD
Primary sclerosing cholangitis remains a challenging disease to diagnose and manage, due to varying presentations, associated disease processes, and lack of targeted treatment.
The Latest
Study supports sex- and comorbidity-based cutoffs for stopping Barrett's surveillance
-
by Alun Evans
“Most physicians make future surveillance decisions heavily based on perceived risk for EAC without considering … life expectancy.”
Thiopurines can be safely stopped when switching to subcutaneous infliximab, trial finds
-
by Olivia Anderson
MINIMISE trial found no rise in antidrug antibodies or disease activity at 24 weeks after withdrawal.
Switching to subcutaneous infliximab may cut treatment failure in IBD
-
by Bob Alaburda
Randomized trial finds 48-week treatment failure dropped from 40% to 15% after switching from IV.
Better onboarding may help GI practices retain APPs
-
by Doug Brunk
Practical strategies from GI experts focus on mentorship, staged autonomy, and avoiding early burnout.
ESMR-L found noninferior to ESD in rectal NETs
-
by Julie Greenbaum
Randomized trial shows comparable resection with shorter procedures and lower costs.
